Hepatitis B and C co-infection linked to worse liver fibrosis than hepatitis B alone
Statin use associated with lower risk of liver decompensation and death in hepatitis C patients with cirrhosis
Civacir immune globulin may help prevent HCV reinfection after liver transplant
People with hepatitis C have higher cancer rates, even when excluding liver cancer
Sofosbuvir-based therapy effective for hepatitis C patients with decompensated cirrhosis
Sofosbuvir, daclatasvir and ribavirin cures hepatitis C for most people with advanced cirrhosis or liver transplants
Merck HCV combination achieves 90% cure in advanced cirrhosis
Deferring hepatitis C treatment can lead to liver cancer and death, despite cure
Progression to severe fibrosis or cirrhosis is common among baby boomers with hepatitis C in the US
